DEVELOPMENT AND VALIDATION OF LIQUID CHROMATOGRAPHIC METHOD FOR THE SIMULTANEOUS ESTIMATION OF EZETIMIBE AND LOVASTATIN IN HUMAN PLASMA

In the present study conditions were optimized for the development and validation of a simple, sensitive and isocratic reverse phase high performance liquid chromatographic method for the simultaneous determination of ezetimibe and lovastatin in human plasma using gemfibrozil as internal standard. A...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: ULLAH KHAN,ISLAM, KAUSAR,TAYYABA, ASHFAQ,MUHAMMAD, SHARIF,SHAHZAD
Lenguaje:English
Publicado: Sociedad Chilena de Química 2010
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-97072010000400011
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0717-97072010000400011
record_format dspace
spelling oai:scielo:S0717-970720100004000112011-05-25DEVELOPMENT AND VALIDATION OF LIQUID CHROMATOGRAPHIC METHOD FOR THE SIMULTANEOUS ESTIMATION OF EZETIMIBE AND LOVASTATIN IN HUMAN PLASMAULLAH KHAN,ISLAMKAUSAR,TAYYABAASHFAQ,MUHAMMADSHARIF,SHAHZAD HPLC plasma diode array detector gemfibrozil In the present study conditions were optimized for the development and validation of a simple, sensitive and isocratic reverse phase high performance liquid chromatographic method for the simultaneous determination of ezetimibe and lovastatin in human plasma using gemfibrozil as internal standard. After a single step extraction with acetonitrile, satisfactory elution of both the analytes along with internal standard was achieved on a Merck C-18 column using a mixture of 0.1 M ammonium acetate pH 5.0 and acetonitrile in the ratio of (28:72, v/v) at a flow rate of 1.5 ml/min. The detection was carried out at a wavelength of 240 nm using a photodiode array detector. The method was linear in the concentration range of 0.2-25 |xg/ml for ezetimibe and 0.4-50 |xg/ml for lovastatin. The extraction recovery of analytes was greater than 85 % and within day and between day precision was also satisfactory. The method was validated by performing its linearity, recovery, precision, LOD/LOQ values and stability of solutions. The total eluting time for the analysis is less than twelve minutes. As the plasma peaks did not interfere with the peaks of analytes so the method can be used for the determination of ezetimibe and lovastatin in human plasma and may possibly be for the pharmacokinetic study.info:eu-repo/semantics/openAccessSociedad Chilena de QuímicaJournal of the Chilean Chemical Society v.55 n.4 20102010-12-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-97072010000400011en10.4067/S0717-97072010000400011
institution Scielo Chile
collection Scielo Chile
language English
topic HPLC
plasma
diode array detector
gemfibrozil
spellingShingle HPLC
plasma
diode array detector
gemfibrozil
ULLAH KHAN,ISLAM
KAUSAR,TAYYABA
ASHFAQ,MUHAMMAD
SHARIF,SHAHZAD
DEVELOPMENT AND VALIDATION OF LIQUID CHROMATOGRAPHIC METHOD FOR THE SIMULTANEOUS ESTIMATION OF EZETIMIBE AND LOVASTATIN IN HUMAN PLASMA
description In the present study conditions were optimized for the development and validation of a simple, sensitive and isocratic reverse phase high performance liquid chromatographic method for the simultaneous determination of ezetimibe and lovastatin in human plasma using gemfibrozil as internal standard. After a single step extraction with acetonitrile, satisfactory elution of both the analytes along with internal standard was achieved on a Merck C-18 column using a mixture of 0.1 M ammonium acetate pH 5.0 and acetonitrile in the ratio of (28:72, v/v) at a flow rate of 1.5 ml/min. The detection was carried out at a wavelength of 240 nm using a photodiode array detector. The method was linear in the concentration range of 0.2-25 |xg/ml for ezetimibe and 0.4-50 |xg/ml for lovastatin. The extraction recovery of analytes was greater than 85 % and within day and between day precision was also satisfactory. The method was validated by performing its linearity, recovery, precision, LOD/LOQ values and stability of solutions. The total eluting time for the analysis is less than twelve minutes. As the plasma peaks did not interfere with the peaks of analytes so the method can be used for the determination of ezetimibe and lovastatin in human plasma and may possibly be for the pharmacokinetic study.
author ULLAH KHAN,ISLAM
KAUSAR,TAYYABA
ASHFAQ,MUHAMMAD
SHARIF,SHAHZAD
author_facet ULLAH KHAN,ISLAM
KAUSAR,TAYYABA
ASHFAQ,MUHAMMAD
SHARIF,SHAHZAD
author_sort ULLAH KHAN,ISLAM
title DEVELOPMENT AND VALIDATION OF LIQUID CHROMATOGRAPHIC METHOD FOR THE SIMULTANEOUS ESTIMATION OF EZETIMIBE AND LOVASTATIN IN HUMAN PLASMA
title_short DEVELOPMENT AND VALIDATION OF LIQUID CHROMATOGRAPHIC METHOD FOR THE SIMULTANEOUS ESTIMATION OF EZETIMIBE AND LOVASTATIN IN HUMAN PLASMA
title_full DEVELOPMENT AND VALIDATION OF LIQUID CHROMATOGRAPHIC METHOD FOR THE SIMULTANEOUS ESTIMATION OF EZETIMIBE AND LOVASTATIN IN HUMAN PLASMA
title_fullStr DEVELOPMENT AND VALIDATION OF LIQUID CHROMATOGRAPHIC METHOD FOR THE SIMULTANEOUS ESTIMATION OF EZETIMIBE AND LOVASTATIN IN HUMAN PLASMA
title_full_unstemmed DEVELOPMENT AND VALIDATION OF LIQUID CHROMATOGRAPHIC METHOD FOR THE SIMULTANEOUS ESTIMATION OF EZETIMIBE AND LOVASTATIN IN HUMAN PLASMA
title_sort development and validation of liquid chromatographic method for the simultaneous estimation of ezetimibe and lovastatin in human plasma
publisher Sociedad Chilena de Química
publishDate 2010
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-97072010000400011
work_keys_str_mv AT ullahkhanislam developmentandvalidationofliquidchromatographicmethodforthesimultaneousestimationofezetimibeandlovastatininhumanplasma
AT kausartayyaba developmentandvalidationofliquidchromatographicmethodforthesimultaneousestimationofezetimibeandlovastatininhumanplasma
AT ashfaqmuhammad developmentandvalidationofliquidchromatographicmethodforthesimultaneousestimationofezetimibeandlovastatininhumanplasma
AT sharifshahzad developmentandvalidationofliquidchromatographicmethodforthesimultaneousestimationofezetimibeandlovastatininhumanplasma
_version_ 1718445437485056000